The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
75 jobs Number of planned job creations
Announcement Date
23 December 2025
Employment effect (start)
23 December 2025
Foreseen end date
23 December 2026
Description
Sanofi España is recruiting 300 new employees, expanding its existing local workforce from 400 to 700 professionals in its new artificial intelligence (AI) and digital innovation hub in Barcelona, after an investment of €150 million.
This Barcelona hub will specialise in AI, R&D, and digital capabilities aimed at optimising the entire pharmaceutical value chain, from drug discovery to production and distribution. Sanofi has already hired 75 of the planned 300 new staff, focusing on highly specialised profiles such as data scientists, bioinformaticians, machine learning experts, and clinical research professionals. Recruitment is expected to continue throughout 2026. The Barcelona hub has grown into a strategic innovation node due to its strong talent pool and thriving scientific and technological ecosystem.
Eurofound (2025), Sanofi España, Business expansion in Spain, factsheet number 203913, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/203913.